By: IPP Bureau
Last updated : July 18, 2025 1:05 pm
Aims to support healthcare practitioners with evidence-based cough categorization tools that enable choosing the right molecules for effective & targeted relief from cough
Kenvue, the world’s largest pure-play consumer health company by revenue today and makers of Benadryl, a renowned brand in cough category, pioneers ‘Cough Clinics’, an industry-first initiative in association with the Association of Physicians of India (API).
As part of this scientific initiative, Kenvue plans to establish 10 Cough Centres of Excellence across India. These centres will run ‘Cough Clinics’ with an aim to scale knowledge on scientific best practices around cough evaluation and expand its usage in treatment.
The first Cough Centre of Excellence has been launched in Mumbai at BSES Hospital, Andheri.
Commenting on launch of this new initiative, Prashant Shinde, Business Unit Head, Self-Care, Kenvue India, said, “Benadryl has been trusted by doctors for over 50 years... We are excited to collaborate with API as we jointly simplify cough management with this pioneering initiative which will help provide crucial clinical training to healthcare professionals and equip them to follow evidence-based management strategies in cough.”
Dr. Agam Vora, Hon. General Secretary, API, shares, “Despite the high burden of cough-related consultations in India, standardized diagnostic tools have largely been missing in primary care, leading to overdependence on empirical treatment and missed opportunities for early intervention. We are delighted to launch India’s first ever Cough Clinics in association with Kenvue to offer physicians in primary care with specialized training and tools to understand different types of coughs and improve patient care.”
The Cough Clinics will comprise of three learning modules. Each module is designed to focus on specific aspects of cough evaluation, sound recognition, treatment decision-making, and rational treatment. The content has been curated and validated by experts from the Association of Physicians of India (API), and each session will be anchored by leading Pulmonologists.
Every participating physician will undergo a thorough assessment to measure the knowledge shift as well as a Net Promoter Score (NPS) will be collected to evaluate experience and effectiveness.
Dr. Harshad Malve, Medical Head Self Care & Operations, Kenvue, “India faces a unique challenge where our cough category is inundated with complex formulations and unwanted ingredients. Our collaboration with API helps us tackle this issue with an aim to bring about a simplified, validated approach to provide effective and safe treatment with targeted formulations. This approach will enhance both diagnostic precision and deliver superior patient outcomes.”